BIOLASE Inc (NASDAQ:BIOL)’s share price traded up 8.2% on Thursday . The company traded as high as $0.56 and last traded at $0.53. 654,797 shares traded hands during trading, an increase of 144% from the average session volume of 268,102 shares. The stock had previously closed at $0.49.
Separately, ValuEngine raised BIOLASE from a “sell” rating to a “hold” rating in a research report on Monday, October 2nd.
The stock has a market capitalization of $40.28, a PE ratio of -1.61 and a beta of 2.32.
ILLEGAL ACTIVITY WARNING: This piece of content was originally published by Markets Daily and is the sole property of of Markets Daily. If you are reading this piece of content on another website, it was stolen and republished in violation of United States and international copyright and trademark law. The legal version of this piece of content can be accessed at https://www.themarketsdaily.com/2018/01/13/biolase-biol-trading-8-2-higher.html.
BIOLASE, Inc (BIOLASE) is a medical device company that develops, manufactures, markets and sells laser systems in dentistry and medicine. The Company markets, sells, and distributes dental imaging equipment, including cone beam digital x-rays and computer-aided design (CAD)/computer-aided manufacturing (CAM) intra-oral scanners, in-office, chair-side milling machines and three-dimensional (3-D) printers.
Receive News & Ratings for BIOLASE Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BIOLASE and related companies with MarketBeat.com's FREE daily email newsletter.